David Andrew Shaw

David Andrew Shaw is a seasoned professional in the field of biomedical and toxicological research, currently serving as a Principal Scientist and Nonclinical Study Manager at Roche since February 2018. Shaw's extensive experience includes roles such as Research Scientist at Central Toxicology Laboratory and Syngenta, where responsibilities encompassed evaluating species differences in response to chemicals and conducting various assays. Previous positions also include Senior Investigator II at Novartis Institutes for Biomedical Research, where Shaw specialized in Preclinical Safety programs, and Regulatory Toxicology Study Director at Covance, managing inhalation and general toxicology studies. Educational qualifications include a Master of Science and a Bachelor of Science in Biomedical Science from The Manchester Metropolitan University.